IRCT2014051117648N1已完成2 期
Evaluation of short-term effect of adding Silymarin versus placebo to standard treatment, in prevention of contrast induced nephropathy in patient undergoing coronary angiography
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •having chronic stable angina; indication of coronary angiograghy; willingness to participate.
- •Exclusion criteria: FBS >=100; eGFR < 60 cc/1.73m2; history of diabetes or kidney disease; having myocardial infarction, unstable angina, or cardiogenic shock; tacking contrast agent during one month before study.
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Effect of silymarin in the treatment of patients with depressioIRCT20160804029191N4Mashhad University of Medical Sciences80
进行中（未招募）
1 期
A dose-finding clinical study investigating the effects of different doses of silymarin compared to placebo on elevated liver enzymes due to drug-induced liver enzyme elevation.EUCTR2020-004645-36-DEFraunhofer Gesellschaft for its Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)156
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
招募中
不适用
Investigation the effect of herbal supplement on lead concentratiolead poisoning.Abnormal lead level in bloodR78.71IRCT20171122037584N1Hamedan University of Medical Sciences60